Xencor Inc — Director's Dealing 2019

Dec 18, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Xencor Inc (XNCR)
CIK: 0001326732
Period of Report: 2019-12-16

Reporting Person: Yang Allen (SVP, Chief Medical Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-12-16	Common Stock	A	31900	$0.00	Acquired	31900	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-12-16	Stock Option (Right to Buy)	$37.59	A	62300	Acquired	2029-12-15	Common Stock (62300)	Direct

Footnotes

F1: Represents restricted stock units that vest as follows: 1/3 of the shares vest on the first, second and third anniversaries of the date of grant.

F2: 1/4th of the shares vest one year after December 16, 2019 (the "Vesting Commencement Date"); the balance of the shares vest in a series of 36 successive equal monthly installments measured from the first anniversary of the Vesting Commencement Date, subject to the optionholder's Continuous Service (as defined in the 2013 Equity Incentive Plan) as of each such date.